Delivery Order SPE2DB20D2014-SPE2DB25FC57K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $40,377.08 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by June 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $17,488.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside delivery order is scheduled for ultimate completion on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,318.31 for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,855.67 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, firm fixed price delivery order is set to be completed by August 26, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,499.50 by the Defense Logistics Agency (DLA) on December 22, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 23, 2025, and performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,815.75 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with ultimate completion by August 13, 2025, represents a single procurement under the company's larger indefinite delivery contract with DLA. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a $4,058.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded without set-aside provisions and is scheduled for completion by October 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $26,393.22 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a child order under a larger contract vehicle. The delivery is to be performed...
- The Defense Logistics Agency awarded a delivery order valued at $14,110.96 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price, non-set-aside delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a $19,479.73 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product for the treatment of rheumatoid arthritis. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract includes no...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC57KDelivery Order
The Defense Logistics Agency awarded a $4,635.46 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, providing a comprehensive pharmaceutical procurement vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical supply requirements through competitive procurement processes. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the company's ongoing role in supporting military medical logistics through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/28/25 |